Chi Advisors LLC Precision Biosciences Inc Transaction History

Chi Advisors LLC

$203 Million
Q3 2023

A detailed history of Chi Advisors LLC transactions in Precision Biosciences Inc stock. As of the latest transaction made, Chi Advisors LLC holds 606,629 shares of DTIL stock, worth $2.73 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

606,629

Previous 1,603,557 62.17%

Holding current value

$2.73 Million

Previous $849,000 75.74%

% of portfolio

0.1%

Previous 0.32%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.34 - $0.69 $338,955 - $687,880	-996,928 Reduced 62.17%	606,629 $206,000
Q2 2023 Aug 11, 2023	SELL	$0.52 - $0.91 $970,456 - $1.7 Million	-1,866,263 Reduced 53.79%	1,603,557 $849,000
Q1 2023 May 11, 2023	SELL	$0.7 - $1.41 $56,000 - $112,800	-80,000 Reduced 2.25%	3,469,820 $2.6 Million
Q4 2022 Feb 13, 2023	SELL	$0.97 - $45.0 $121,250 - $5.63 Million	-125,000 Reduced 3.4%	3,549,820 $4.22 Million
Q3 2022 Nov 09, 2022	BUY	$1.22 - $40.8 $818,704 - $27.4 Million	671,069 Added 22.34%	3,674,820 $4.78 Million
Q2 2022 Aug 12, 2022	BUY	$1.15 - $3.34 $2.76 Million - $8.01 Million	2,397,122 Added 395.15%	3,003,751 $4.81 Million
Q4 2021 Feb 11, 2022	SELL	$7.4 - $11.66 $296,740 - $467,566	-40,100 Reduced 6.2%	606,629 $4.49 Million
Q3 2021 Nov 15, 2021	SELL	$9.18 - $14.15 $45,900 - $70,750	-5,000 Reduced 0.77%	646,729 $7.46 Million
Q2 2021 Aug 11, 2021	SELL	$8.07 - $12.52 $321,993 - $499,548	-39,900 Reduced 5.77%	651,729 $8.16 Million
Q1 2021 May 14, 2021	SELL	$8.57 - $15.79 $1.38 Million - $2.54 Million	-160,729 Reduced 18.86%	691,629 $7.16 Million
Q4 2020 Feb 12, 2021	SELL	$5.98 - $12.47 $971,642 - $2.03 Million	-162,482 Reduced 16.01%	852,358 $7.11 Million
Q3 2020 Nov 12, 2020	BUY	$4.65 - $8.73 $254,820 - $478,404	54,800 Added 5.71%	1,014,840 $6.25 Million
Q2 2020 Aug 12, 2020	BUY	$4.66 - $8.7 $90,776 - $169,476	19,480 Added 2.07%	960,040 $8 Million
Q1 2020 May 14, 2020	BUY	$5.05 - $15.01 $293,920 - $873,612	58,202 Added 6.6%	940,560 $5.67 Million
Q4 2019 Feb 14, 2020	SELL	$6.32 - $19.66 $1.27 Million - $3.96 Million	-201,428 Reduced 18.59%	882,358 $12.3 Million
Q3 2019 Nov 12, 2019	BUY	$8.03 - $14.82 $8.7 Million - $16.1 Million	1,083,786 New	1,083,786 $9.09 Million

Others Institutions Holding DTIL

# of Institutions

Shares Held

2.56M

Call Options Held

Put Options Held

View Full List

About PRECISION BIOSCIENCES INC

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $499M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

More about DTIL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chi Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chi Advisors LLC with notifications on news.

Account